Update on biologic safety for patients with psoriasis during pregnancy.
about
Safety Profile of Anticancer and Immune-Modulating Biotech Drugs Used in a Real World Setting in Campania Region (Italy): BIO-Cam Observational StudyChoosing First-Line Biologic Treatment for Moderate-to-Severe Psoriasis: What Does the Evidence Say?A Review of the Use of Secukinumab for Psoriatic Arthritis.Persistence rates and medical costs of biological therapies for psoriasis treatment in Japan: a real-world data study using a claims database.
P2860
Update on biologic safety for patients with psoriasis during pregnancy.
description
2017 nî lūn-bûn
@nan
2017 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Update on biologic safety for patients with psoriasis during pregnancy.
@ast
Update on biologic safety for patients with psoriasis during pregnancy.
@en
type
label
Update on biologic safety for patients with psoriasis during pregnancy.
@ast
Update on biologic safety for patients with psoriasis during pregnancy.
@en
prefLabel
Update on biologic safety for patients with psoriasis during pregnancy.
@ast
Update on biologic safety for patients with psoriasis during pregnancy.
@en
P2860
P1476
Update on biologic safety for patients with psoriasis during pregnancy.
@en
P2093
Martina L Porter
Stephen J Lockwood
P2860
P356
10.1016/J.IJWD.2016.12.003
P577
2017-02-04T00:00:00Z